Page 24 - Bharat Biotech

Kejriwal lauds scientists and doctors after DCGI nod to two Covid vaccines

Delhi Chief Minister Arvind Kejriwal said that approval for the emergency use of two "made in India" vaccines will give a positive direction to the country's fight against coronavirus

WHO hails India's emergency use authorisation approval to Covid vaccines

World Health Organisation (WHO) has welcomed India's decision giving emergency use authorisation to Covid-19 vaccines, informed Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia

A decisive turning point: PM Modi on coronavirus vaccine approval

Prime Minister Modi lauded scientists of the country after DCGI gave approval to Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use

Our goal now is to provide it globally: Bharat Biotech on Covaxin approval

Bharat Biotech on Sunday said the approval for emergency use of its Covid-19 vaccine-- Covaxin-- is a giant leap for innovation and novel product development in India

Approval for vaccines accelerates India's journey to be Covid-free: Modi

Modi said it will make every Indian proud that both the vaccines are made in India

India approves two coronavirus vaccines for restrictive, emergency use

Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use

'Covishield' vaccine ready to roll out in coming weeks: Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca COVID-19 vaccine 'Covishield' is ready to roll out in the coming weeks. Poonawalla's remarks came soon after after India's drugs regulator approved Covishield for restricted emergency use. "Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks," Poonawalla tweeted. "Thank you Hon. Sri @narendramodi Ji, Hon. Sri @drharshvardhan Ji, @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support," he added.

Bharat Biotech recruits 23,000 volunteers for Phase-3 Covaxin trials so far

The Phase III human clinical trials of Covaxin, which began in mid-November last year, require 26,000 volunteers across India

Expert panel clears Bharat Biotech's vaccine for restricted emergency use

This comes a day after giving similar direction for the Oxford Covid-19 vaccine

Serum Institute gets SEC thumbs up; Bharat Biotech proposal being discussed

US giant Pfizer did not come to present its case on Friday before the Subject Expert Committee

Drug controller hints vaccine approval will make it a 'happy new year'

V G Somani's statement comes even as subject expert committee is set to meet on Jan 1 to consider three emergency-use authorisation applications

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Sources close to the development said the expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine

CDSCO panel to reconvene on Jan 1 to consider vaccine's emergency use

An expert panel in the Central Drugs Standard Control Organisation that met on Wednesday to consider emergency use authorisation applications will reconvene on Jan 1 to deliberate on the matter.

Drug regulator to meet again on Jan 1 to discuss AstraZeneca vaccine

India is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech

Covaxin can deal with new Covid strains too: Bharat Biotech chairman

Bharat Biotech's Chairman Krishna Ella said on Tuesday that its vaccine candidate, Covaxin, will be effective in dealing with new strains of coronavirus.

Gujarat: Over 750 volunteers get Covaxin first dose in phase-3 trial

None of them have experienced any side effects so far, a senior doctor said on Sunday

Vice President discusses status of indigenous vaccine against Covid-19

Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella called on the Vice President M Venkaiah Naidu in Hyderabad

Bharat Biotech's top brass calls on Vice President Venkaiah Naidu

Bharat Biotech's top brass on Friday called on Vice President M Venkaiah Naidu in Hyderabad

Biotech's Covaxin shows good results in clinical trials: Research paper

Covaxin, being developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is now undergoing phase-3 trials

People who are infected should also take vaccine: Bharat Biotech Chairman

People who are infected should also take a vaccine,and India is well prepared regarding the logistics for the vaccine distribution,Bharat BiotechChairman & MD Krishna Ella said on Wednesday. He was speaking in a virtual session on 'Sero surveillance significance in immunogenicity and safety in pre and post vaccination era' organised by industrybody CII. For the peoplewho are infected,shouldthey take a vaccine, "the answeris yes", becausethey may not have a goodT cells response..., Ella said. Talking about the company's efficacy trials of its COVID-19 vaccine, he said that for the efficacy trials the company has taken 24 centres all over the country so that it has tier I ,tierIIand tier III cities to capture the efficacy in a better way. On the distribution of vaccines in India, he said India is well prepared for that and Indian immunisation system is very robust, Ella said. Speaking at the session, Biocon ChairpersonKiran Mazumdar Shaw said, "We have to ensure we have a sense of .